
X
Data sets up 2021 filings for Gilead’s twice-a-year HIV drug lenacapavir
https://pharmaphorum.com/news/data-sets-up-2021-filings-for-gileads-twice-a-year-hiv-drug-lenacapavir/
Trial involves generics supplied by Mylan.
Large trial of HIV PrEP could lead to national programme